Abstract:Trypsin is an important enzyme secreted by the pancreas for digesting proteins. The precursors of major human trypsin are encoded by trypsinogen genes PRSS1 and PRSS2 . Here, we leveraged multi-omic data to study their evolutionary and functional impact. We estimated that the primate trypsinogen gene was duplicated from a single copy to multiple-copy 24-34 million years ago (Mya). Compared to six protein-coding genes in non-human great apes, the human ancestral state was a 5-copy with three being pseudogenized. Interestingly, a derived 3-copy form emerged in Africans ∼260 Kya and dominated in non-Africans as one of the two major haplotypes. Although no longer encoding proteins, the pseudogene enhancers still function on pancreatic PRSS2 expression, leading to ∼15% up-regulation for the 5-copy than the 3-copy haplotype. Notably, the 3-copy structure was under positive selection in East Asians, where lower trypsin might be adaptive during high-starch diet shift for protecting the pancreas from autodigestion, as also supported by the identified causality of the haplotype structure to pancreatitis risk. Our efforts in elucidating the structural evolution of trypsinogen genes advance our understanding of the genetic basis and molecular mechanism of human pancreas diseases.### Competing Interest StatementThe authors have declared no competing interest.### Funding StatementThis study was supported by the National Natural Science Foundation of China (NSFC) grant (32030020, 31871256, and 31961130380), the Strategic Priority Research Program (XDPB17, XDB38000000) of the Chinese Academy of Sciences (CAS), the UK Royal Society-Newton Advanced Fellowship (NAF\R1\191094), and the Shanghai Municipal Science and Technology Major Project (2017SHZDZX01). The funders had no role in the study design, data collection, analysis, decision to publish, or preparation of the manuscript.### Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study used ONLY openly available human data that were originally located at NCBI, ENCODE project, 1000 Genomes Project, Human Genome Diversity Project, SEER and GTEx project.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are publicly available online, see 'Data Availability' section in the manuscript for accession numbers.

Trypsinogen (PRSS1 and PRSS2) gene dosage correlates with pancreatitis risk across genetic and transgenic studies: a systematic review and re-analysis

Structural Evolution of Trypsinogen Gene Redundancy Confers Risk for Pancreas Diseases

Trypsin Activity Governs Increased Susceptibility to Pancreatitis in Mice Expressing Human PRSS1R122H

The PRSS3P2 and TRY7 Deletion Copy Number Variant Modifies Risk for Chronic Pancreatitis.

Trypsin-Dependent Pathway Gene Variants and Chronic Pancreatitis: A Large Chinese Cohort Study

rs10273639 C/C Genotype of &ITPRSS1&IT: How Can It Affect Management of Pancreatic Cancer?

The Differential Role of Human Cationic Trypsinogen (PRSS1) p.R122H Mutation in Hereditary and Nonhereditary Chronic Pancreatitis: A Systematic Review and Meta-Analysis

Multisite Heterozygous Mutations of PRSS1 Gene and Clinical Characterization of Patients with Hereditary Pancreatitis in the Chinese

Pancreatitis polygenic risk score is independently associated with all‐cause acute pancreatitis risk in the UK Biobank

Genetic analysis of the STIM1 gene in chronic pancreatitis

Genetic Abnormalities in Pancreatitis: An Update on Diagnosis, Clinical Features, and Treatment

Genetic background is different between sentinel and recurrent acute pancreatitis.

A common CTRB misfolding variant associated with pancreatic cancer risk causes ER stress and inflammation in mice

Trypsin mediates nociception via the proteinase-activated receptor 2: A potentially novel role in pancreatic pain

A Loss-Of-Function Anionic Trypsinogen (Prss2) Variant In Japanese Patients With Pancreatic Diseases

Trypsin-Mediated Sensitization to Ferroptosis Increases the Severity of Pancreatitis in Mice

Protease-Sensitive Pancreatic Lipase Variants Are Associated with Early Onset Chronic Pancreatitis

Pancreatitis polygenic risk score is associated with acute pancreatitis in multifactorial chylomicronemia syndrome

Novel chymotrypsin C (CTRC) variants from real-world genetic testing of pediatric chronic pancreatitis cases

Framework for interpretation of trypsin-antitrypsin imbalance and genetic heterogeneity in pancreatitis

The Polymorphisms at PRSS1-PRSS2 and MORC4 Loci and the Risk of Post-ERCP Pancreatitis